Zobrazeno 1 - 10
of 23
pro vyhledávání: '"V E, Pogorelyĭ"'
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 77(2)
Neuroprotective properties of the new derivative of glutamic and apovincaminic acids, ethyl -(3-alpha,16-alpha)-eburnamenin-14-carbopxylate of 2-aminopentadionic acid (LHT 1-02) were studied on a model of acute brain ischemia in cats. LHT 1-02 has pr
Autor:
L M, Makarova, V E, Pogorelyĭ
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 76(7)
Comparative study of antihypoxic activity of glutamic and N-acetylglutamic acid in doses of 1, 10, 50 and 100 mg/kg was realized. It was experimentally ascertained that the most apparent antihypoxic action of study objects occurs in conditions of hyp
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 70(3)
The effect of glucosamine sulfate on the analgesic properties and ulcerogenic action of ketoprofen has been experimentally studied in the course of drug adminstration in laboratory animals in comparison to the ketoprofen monotherapy. An analysis of t
Autor:
L M, Makarova, V E, Pogorelyĭ
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 69(6)
The effect of glycine and its phosphorylated derivative (AKF 90-7) on the ischemic brain injury in experimental animals has been studied. The therapeutic injection of glycine and AKF 90-7 (50 100 mg/kg) increased the survival of laboratory animals un
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 69(5)
Neuroprotector properties of a new apovincaminic acid derivative (LHT 2 - 02) were studied on a model of acute brain ischemia in cats. LHT 2 - 02 has proved to be more effective than the reference drugs vinpocetin and glycine in preventing the reperf
Autor:
L P, Makarova, V E, Pogorelyĭ
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 67(5)
Neuroprotector properties of a new phosphorylated derivative of asparagic acid (PIR 87-65-0) were studied on a model of acute brain ischemia in cats. PIR 87-5-0 has proved to be more effective than the reference drug vinpocetin in preventing the repe
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 66(1)
A new drug composition containing pyroglutamic acid and pyrrolidone produces a significant effect on the cerebral circulation in rats with global recurrent brain ischemia and in a model ischemic state under high radial gravitational overload. In the
Autor:
V E, Pogorelyĭ, L M, Makarova
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 65(4)
It was experimentally established that prophylactic introduction of a Rhodiola Rosea extract prevents the ischemic brain damage development. A course administration of the drug in a dose of 700 mg/kg arrests the development of hyper- and hypoperfusio
Autor:
V E, Pogorelyĭ, M D, Gaevyĭ
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 62(6)
Acute experiments were conducted on rats under nembutal anesthesia to compare the efficacy of emoxipin with that of lithium oxybutyrate and picamilon in the postischemic period after preventive and therapeutic injections in various doses. Emoxipin pr
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 62(5)
The effect of the antioxidant mexidol and two new derivatives of 3-oxypyridine, namely LBK-10 and LBK-39 on the circulation of blood and metabolism of the brain in the postischemic period was studied in acute experiments on narcotized cats under cond